Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, destructiveHint=false and openWorldHint=false, so safety and closed-domain scope are covered structurally. The description adds the output content ('RETURNS: 转化研究假说与实验方案'), which matters because there is no output schema. It does not disclose that the output is generated hypotheses rather than evidence-backed findings, nor any caveats about validating them, which is the behavior an agent most needs to know here.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The pipe-delimited layout is scannable and front-loads the title and USE WHEN trigger. However, a large share of the text is a bilingual alias/keyword list (转化研究, bench to bedside, Bridge, 实验方案建议) that serves retrieval matching rather than agent comprehension, and the title is restated in both the header and the annotations.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a two-parameter, single-purpose tool with no output schema, the description supplies the trigger and the return content, which is close to sufficient. Gaps remain: the optional 'direction' parameter's default is never stated, and there is no indication of output shape or depth (how many hypotheses, whether experiments come with rationale). Adequate but not complete.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so 'finding' and 'direction' are already documented, including the two direction values. The description's 'or the reverse' reinforces the direction parameter's meaning but adds no syntax, defaults, or constraints (e.g. what happens if direction is omitted despite being optional). Baseline 3 applies when the schema carries the parameter burden.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The USE WHEN clause states a concrete transformation: from a clinical finding, propose mechanistic hypotheses and experiments (and the reverse). That is a specific verb (propose hypotheses/experiments) plus a resource (translational bridge), so an agent can tell it apart from analysis siblings like roc_auc or qpcr_ddct. It stops short of naming the nearest conceptual neighbors (act_experiment_plan, act_idea_ignite, study_design_advisor), so sibling differentiation is implicit rather than explicit.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is one explicit trigger condition — 'from a clinical finding propose mechanistic hypotheses and experiments (or the reverse)' — which also implies the bidirectional case. It gives no when-not guidance and no named alternative for cases where the agent just needs a plain experiment plan (act_experiment_plan) or an idea brainstorm (act_idea_ignite). Clear context, but routing under ambiguity is left to inference.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.